ARTICLE | Company News
Therion deal
October 10, 1994 7:00 AM UTC
Therion entered into a five-year Collaborative Research and Development Agreement (CRADA) with the National Cancer Institute to develop immunotherapeutic vaccines for cancer. NCI will supply Therion w...